Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;50(11):9715-9720.
doi: 10.1007/s11033-023-08764-z. Epub 2023 Oct 9.

NGS study in a sicilian case series with a genetic diagnosis for Gerstmann-Sträussler-Scheinker syndrome (PRNP, p.P102L)

Michele Salemi  1 , Luana G M Mandarà  2 , Maria Grazia Salluzzo  3 , Francesca A Schillaci  3 , Roberto Castiglione  4 , Angela Cordella  5   6 , Roberta Iorio  5   6 , Concetta Simona Perrotta  2 , Raffaele Ferri  3 , Corrado Romano  3   7
Affiliations

NGS study in a sicilian case series with a genetic diagnosis for Gerstmann-Sträussler-Scheinker syndrome (PRNP, p.P102L)

Michele Salemi et al. Mol Biol Rep. 2023 Nov.

Abstract

Background: Gerstmann Sträussler Scheinker (GSS) is an inherited, invariably fatal prion disease. Like other human prion diseases, GSS is caused by missense mutations in the prion protein (PrP) gene (PRNP), and by the formation and overtime accumulation of the misfolded, pathogenic scrapie PrP (PrPSc). The first mutation identified in the PRNP gene, and the one blamed as the main cause of the disease, is c.C305T:p.P102L.

Methods and results: The Sanger sequencing method was performed on the PRNP gene for the detection of c.C305T:p.P102L mutations in a cohort of 10 subjects; moreover, a study was carried out, using Next Generation Sequencing (NGS), by sequencing a group of genes related to amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), movement disorders and dementia which show a phenotypic profile similar to that of GSS. The results obtained from the study using NGS indicate the potential role of other genetic variants which could contribute to the various GSS phenotypes.

Conclusions: In conclusion, we highlight the large clinical variability in subjects presenting with GSS and p.P102L, as well as the hypothesis that the mutation in PrP codon 102 alone is not sufficient to trigger the cardinal clinical signs of the disease; furthermore, we do not exclude the possibility that further genetic variants play a decisive role in the aspects of the various phenotypes with which GSS manifests itself.

Keywords: Gerstmann-Sträussler-Scheinker syndrome; Neurodegenerative diseases; Next generation sequencing; PRNP gene.

PubMed Disclaimer

References

    1. Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D et al (1998) Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57:979–988 - DOI - PubMed
    1. Doh-ura K, Tateishi J, Sasaki H, Kitamoto T, Sakaki Y (1989) Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 163:974–979 - DOI - PubMed
    1. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 9(4542):136–144 - DOI
    1. Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H et al (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A. 7;95(14):8322–7
    1. Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S (2014) Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat. 2018;14:2067–85

MeSH terms

LinkOut - more resources